Chief Executive Officer
Pantec Biosolutions AG
The target component to address in this case is the epidermis. The hand held device creates the micro-pores. They can control the accurate array of micro-pores. It’s without pain and causes small amounts of damage. It is independent of the skin condition.
Regulatory and intellectual property estate. One product: IVF001, IVF002, both for infertility. They can get the protein across the skin at therapeutic levels. The protein can be delivered from the patch at therapeutic concentrations.
The delivery of vaccines – application of ovalbumin using P.L.E.A.S.E. ® lead to activation of APCs. The immunization with recombinant proteins using please is superior to interdermal needle injection.
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment